Ming Lin
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Microscopic Colitis
- Hepatitis B Virus Studies
Papers in
- Epidemiology 20
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 9
- Microscopic Colitis 5
- Hepatology 14
- Hepatitis C virus research 11
- Co-authors
- Wojciech Błoński (13 shared papers)Raymond T. Chung (6 shared papers)Gary R. Lichtenstein (8 shared papers)Manuel Mendizábal (4 shared papers)David Kotlyar (6 shared papers)David L. Porter (2 shared papers)Mariusz A. Wasik (1 shared paper)Mark T. Osterman (4 shared papers)
- Journals
- Gastroenterology (7 papers)The American Journal of Gastroenterology (4 papers)Annals of Oncology (3 papers)European Journal of Surgical Oncology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- United StatesChinaPoland
In The Last Decade
Ming Lin
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Hepatology 423
- Epidemiology 442
- Transplantation 32
- Genetics 315
- Infectious Diseases 99
Countries citing papers authored by Ming Lin
This map shows the geographic impact of Ming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Lin more than expected).
Fields of papers citing papers by Ming Lin
This network shows the impact of papers produced by Ming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Lin. The network helps show where Ming Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 337 | |
| 2 | 2015 | 192 | |
| 3 | 2014 | 80 | |
| 4 | 2016 | 70 | |
| 5 | 2017 | 60 | |
| 6 | 2009 | 59 | |
| 7 | 2010 | 43 | |
| 8 | 2016 | 33 | |
| 9 | 2010 | 30 | |
| 10 | 2016 | 30 | |
| 11 | 2022 | 29 | |
| 12 | 2018 | 25 | |
| 13 | 2015 | 25 | |
| 14 | 2023 | 23 | |
| 15 | 2004 | 21 | |
| 16 | 2010 | 20 | |
| 17 | 2012 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2009 | 12 | |
| 20 | 2022 | 11 |
About Ming Lin
Ming Lin is a scholar working on Epidemiology, Hepatology, Genetics, Surgery and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (9 papers), Inflammatory Bowel Disease (8 papers), Gastric Cancer Management and Outcomes (5 papers), Microscopic Colitis (5 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Hepatology (423 citations), Epidemiology (442 citations), Transplantation (32 citations), Genetics (315 citations) and Infectious Diseases (99 citations). Ming Lin has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Wojciech Błoński, Raymond T. Chung, Gary R. Lichtenstein, Manuel Mendizábal, David Kotlyar, David L. Porter, Mariusz A. Wasik, Mark T. Osterman, Robert H. Diamond and Lindsay Y. King. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Annals of Oncology, European Journal of Surgical Oncology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.